Skip to main content
. 2016 Mar 15;13(3):e1001975. doi: 10.1371/journal.pmed.1001975

Fig 5. Comparative cost-effectiveness analysis of the three vaccine candidates based on the base-case EVCmax.

Fig 5

The color coding indicates the optimal vaccine given the costs of the three vaccines (V Vigoo, V Sinovac, V CAMS).